I. I. de Cáceres

Tumor Cell-Specific BRCA1 and RASSF1A Hypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients

Paul Cairns, Manel Esteller, J. Herman, 2004, Cancer Research.

Author Correction: The SEQC2 epigenomics quality control (EpiQC) study

Raymond G. Cavalcante, Paweł P. Łabaj, Matthew A. Campbell, 2021, Genome biology.

VILIP-1 Downregulation in Non-Small Cell Lung Carcinomas: Mechanisms and Prediction of Survival

A. Bellacosa, D. Bassi, P. Cairns, 2008, PloS one.

Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients

Paul Cairns, P. Cairns, E. Dulaimi, 2004, Clinical Cancer Research.

MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species

T. Sellers, V. Gonzalez, R. León, 2018, Translational research : the journal of laboratory and clinical medicine.

Promoter Hypermethylation Profile of Kidney Cancer

R. Uzzo, T. Polascik, W. Grizzle, 2004, Clinical Cancer Research.

The SEQC2 Epigenomics Quality Control (EpiQC) Study: Comprehensive Characterization of Epigenetic Methods, Reproducibility, and Quantification

Raymond G. Cavalcante, Paweł P. Łabaj, Matthew A. Campbell, 2020, bioRxiv.

Correction: VILIP-1 Downregulation in Non-Small Cell Lung Carcinomas: Mechanisms and Prediction of Survival

A. Bellacosa, D. Bassi, P. Cairns, 2013, PLoS ONE.

The Inhibition of Inducible Nitric Oxide Synthase Reverts Arthritic‐Induced Decrease in Pituitary Growth Hormone mRNA But Not in Liver Insulin‐Like Growth Factor I mRNA Expression

I. I. de Caceres, T. Priego, A. López-Calderón, 2003, Journal of neuroendocrinology.

Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations

A. Abarrategi, R. Perona, L. Sastre, 2014, Cancer medicine.